Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Gampenrieder SP, Pircher M, Fesl C, Rinnerthaler G, Mlineritsch B, Greil-Ressler S, Steger GG, Sagaster V, Fitzal F, Exner R, Devyatko Y, Balic M, Stöger H, Suppan C, Bauernhofer T, Singer CF, Pfeiler G, Seifert M, Helfgott R, Heck D, Rumpold H, Kwasny W, Wieder U, Gnant M, Greil R. Gampenrieder SP, et al. Among authors: bauernhofer t. Breast Care (Basel). 2022 Apr;17(2):137-145. doi: 10.1159/000516157. Epub 2021 May 21. Breast Care (Basel). 2022. PMID: 35707180 Free PMC article.
Clinical Application of ISO and CEN/TS Standards for Liquid Biopsies-Information Everybody Wants but Nobody Wants to Pay For.
Bonstingl L, Skofler C, Ulz C, Zinnegger M, Sallinger K, Schönberger J, Schuch K, Pankratz K, Borrás-Cherrier A, Somodi V, Abuja PM, Oberauner-Wappis L, Moser T, Heitzer E, Bauernhofer T, Kroneis T, El-Heliebi A. Bonstingl L, et al. Among authors: bauernhofer t. Clin Chem. 2024 Sep 3;70(9):1140-1150. doi: 10.1093/clinchem/hvae079. Clin Chem. 2024. PMID: 38958115
Advanced single-cell and spatial analysis with high-multiplex characterization of circulating tumor cells and tumor tissue in prostate cancer: Unveiling resistance mechanisms with the CoDuCo in situ assay.
Bonstingl L, Zinnegger M, Sallinger K, Pankratz K, Müller CT, Pritz E, Odar C, Skofler C, Ulz C, Oberauner-Wappis L, Borrás-Cherrier A, Somođi V, Heitzer E, Kroneis T, Bauernhofer T, El-Heliebi A. Bonstingl L, et al. Among authors: bauernhofer t. Biomark Res. 2024 Nov 16;12(1):140. doi: 10.1186/s40364-024-00680-z. Biomark Res. 2024. PMID: 39550585 Free PMC article.
Consequences of somatic mutations of GIRK1 detected in primary malign tumors on expression and function of G-protein activated, inwardly rectifying, K+ channels.
Pelzmann B, Hatab A, Scheruebel S, Langthaler S, Rienmueller T, Sokolowski A, Gorischek A, Platzer D, Zorn-Pauly K, Jahn SW, Bauernhofer T, Schreibmayer W. Pelzmann B, et al. Among authors: bauernhofer t. Front Oncol. 2022 Oct 31;12:998907. doi: 10.3389/fonc.2022.998907. eCollection 2022. Front Oncol. 2022. PMID: 36483038 Free PMC article.
Correction: Advanced single-cell and spatial analysis with high-multiplex characterization of circulating tumor cells and tumor tissue in prostate cancer: unveiling resistance mechanisms with the CoDuCo in situ assay.
Bonstingl L, Zinnegger M, Sallinger K, Pankratz K, Müller CT, Pritz E, Odar C, Skofler C, Ulz C, Oberauner-Wappis L, Borrás-Cherrier A, Somođi V, Heitzer E, Kroneis T, Bauernhofer T, El-Heliebi A. Bonstingl L, et al. Among authors: bauernhofer t. Biomark Res. 2024 Dec 2;12(1):150. doi: 10.1186/s40364-024-00698-3. Biomark Res. 2024. PMID: 39617911 Free PMC article. No abstract available.
[Breast cancer in the man: a report of 30 patients].
Stöger H, Bauernhofer T, Moser R, Derstvenscheg E, Schmid M, Ploner F, Pakisch B, Wilders-Truschnig M, Haas J, Steindorfer P, et al. Stöger H, et al. Among authors: bauernhofer t. Wien Klin Wochenschr. 1994;106(18):575-80. Wien Klin Wochenschr. 1994. PMID: 7992495 German.
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.
Jakesz R, Hausmaninger H, Kubista E, Gnant M, Menzel C, Bauernhofer T, Seifert M, Haider K, Mlineritsch B, Steindorfer P, Kwasny W, Fridrik M, Steger G, Wette V, Samonigg H; Austrian Breast and Colorectal Cancer Study Group Trial 5. Jakesz R, et al. Among authors: bauernhofer t. J Clin Oncol. 2002 Dec 15;20(24):4621-7. doi: 10.1200/JCO.2002.09.112. J Clin Oncol. 2002. PMID: 12488405 Clinical Trial.
123 results